(+) Evotec: R & D Day (Evotec) - Oct 26, 2013 - P2, N=NA; "DiaPep277-Phase II results"; "C-peptide levels significantly declined in placebo group"; "C-peptide levels were maintained in DiaPep277 group"; "Need for exogenous insulin higher in placebo group; "HbA1c levels around 7% in both groups"; "T cell reactivity shifted towards Th2 cytokine phenotype in DiaPep277 group"
P2 data • Diabetes
|